Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Interfraction movement and clinical outcome of immobilization for thoracic irradiation: A randomized controlled trial

Loading...
Thumbnail Image

Date

Authors

Pulvirenti, Trish
Agustin, Cherry
Tamas, Monica
Harris, Jillian
Verning, Maria
Cross, Shamira
Jayamohan, Jayasingham
Yeghiaian-Alvandi, Roland
Gebski, Val

Journal Title

Journal ISSN

Volume Title

Publisher

John Wiley & Sons Ltd.

Abstract

Objective To evaluate the impact of immobilization on set-up errors and clinical outcomes in patients receiving radiation therapy to the thorax. Methods Patients receiving curative intent radiation therapy to the lung and esophagus were randomized to no immobilization (control) or immobilization (chest jig or vacuum bag), and treatment verification images were acquired within 3 days of commencing treatment and then weekly. The primary outcome was the proportion of patients having a deviation >5 mm from the isocenter. Assessment was carried out blinded to immobilization assignment. Results Of the 77 patients, 75 patients were allocated to either immobilization or control. No statistical difference in the proportion of patients with bony displacements >5 mm from the isocenter were observed (P = 0.5), as was the case for both systematic and random errors between the groups. There was an increased risk of local failure in the immobilized control group (HR 1.46, 95% CI 0.78–2.71, P = 0.23) based on a competing risk analysis. The median overall survival was 18.4 months and 27.0 months in the control and immobilized groups, respectively (HR 0.73, 95% CI 0.51–1.04, P = 0.08). Conclusions The results failed to show benefit with immobilization in reducing set-up errors, local control, and overall survival.

Description

Citation

Source

Precision Radiation Oncology

Book Title

Entity type

Access Statement

Open Access

License Rights

Creative Commons Attribution licence

Restricted until